Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway
SHUICHI IWAHASI(Tokushima University), Mitsuo Shimada(Tokushima University)
Cited by 30
Related Papers
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|267
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway
|International Journal of Oncology|2021|167
Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer
|Anticancer Research|2018|82